The self-expanding stents segment garnered USD 286.3 million in revenue size in 2022 and is projected to witness high demand through 2032 owing to several advantages associated with its use such as minimally invasive deployment, accurate placement, flexibility, reduced risk of complications, and long-term stability. Read More